{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:48:13Z","timestamp":1792806493266,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1038\/s41591-023-02482-6","type":"journal-article","created":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T12:02:17Z","timestamp":1691409737000},"page":"2057-2067","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary"],"prefix":"10.1038","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0978-9605","authenticated-orcid":false,"given":"Intae","family":"Moon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"LoPiccolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvan C.","family":"Baca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9532-9735","authenticated-orcid":false,"given":"Lynette M.","family":"Sholl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-9797","authenticated-orcid":false,"given":"Kenneth L.","family":"Kehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Hassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0346-5033","authenticated-orcid":false,"given":"David","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Schrag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7980-4620","authenticated-orcid":false,"given":"Alexander","family":"Gusev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,7]]},"reference":[{"key":"2482_CR1","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.jare.2014.11.007","volume":"6","author":"N Pavlidis","year":"2015","unstructured":"Pavlidis, N., Khaled, H. & Gaafar, R. A mini review on cancer of unknown primary site: a clinical puzzle for the oncologists. J. Adv. Res. 6, 375\u2013382 (2015).","journal-title":"J. Adv. Res."},{"key":"2482_CR2","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1056\/NEJMra1303917","volume":"371","author":"GR Varadhachary","year":"2014","unstructured":"Varadhachary, G. R. & Raber, M. N. Cancer of unknown primary site. N. Engl. J. Med. 371, 757\u2013765 (2014).","journal-title":"N. Engl. J. Med."},{"key":"2482_CR3","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1056\/NEJMoa1502309","volume":"373","author":"DM Hyman","year":"2015","unstructured":"Hyman, D. M. et al. Vemurafenib in multiple nonmelanoma cancers with BRAF V600 mutations. N. Engl. J. Med. 373, 726\u2013736 (2015).","journal-title":"N. Engl. J. Med."},{"key":"2482_CR4","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1200\/EDBK_100014","volume":"38","author":"JD Hainsworth","year":"2018","unstructured":"Hainsworth, J. D. & Greco, F. A. Cancer of unknown primary site: new treatment paradigms in the era of precision medicine. Am. Soc. Clin. Oncol. Educ. Book 38, 20\u201325 (2018).","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"2482_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/PAI.0b013e3181a75e6d","volume":"18","author":"GG Anderson","year":"2010","unstructured":"Anderson, G. G. & Weiss, L. M. Determining tissue of origin for metastatic cancers: meta-analysis and literature review of immunohistochemistry performance. Appl. Immunohistochem. Mol. Morphol. 18, 3\u20138 (2010).","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"2482_CR6","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1093\/annonc\/mds357","volume":"23","author":"K Oien","year":"2012","unstructured":"Oien, K. & Dennis, J. Diagnostic work-up of carcinoma of unknown primary: from immuno-histochemistry to molecular profiling. Ann. Oncol. 23, 271\u2013277 (2012).","journal-title":"Ann. Oncol."},{"key":"2482_CR7","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(16)30297-2","volume":"17","author":"S Moran","year":"2016","unstructured":"Moran, S. et al. Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis. Lancet Oncol. 17, 1386\u20131395 (2016).","journal-title":"Lancet Oncol."},{"key":"2482_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13825-8","volume":"11","author":"W Jiao","year":"2020","unstructured":"Jiao, W. et al. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns. Nat. Commun. 11, 728 (2020).","journal-title":"Nat. Commun."},{"key":"2482_CR9","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1001\/jamaoncol.2019.3985","volume":"6","author":"A Penson","year":"2020","unstructured":"Penson, A. et al. Development of genome-derived tumor type prediction to inform clinical cancer care. JAMA Oncol. 6, 84\u201391 (2020).","journal-title":"JAMA Oncol."},{"key":"2482_CR10","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3389\/fbioe.2020.00737","volume":"8","author":"B He","year":"2020","unstructured":"He, B. et al. A neural network framework for predicting the tissue-of-origin of 15 common cancer types based on RNA-seq data. Front. Bioeng. Biotechnol. 8, 737 (2020).","journal-title":"Front. Bioeng. Biotechnol."},{"key":"2482_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31666-w","volume":"13","author":"L Nguyen","year":"2022","unstructured":"Nguyen, L., Van Hoeck, A. & Cuppen, E. Machine learning-based tissue of origin classification for cancer of unknown primary diagnostics using genome-wide mutation features. Nat. Commun. 13, 4013 (2022).","journal-title":"Nat. Commun."},{"key":"2482_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/path.6022","volume":"259","author":"A Posner","year":"2023","unstructured":"Posner, A. et al. A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary. J. Pathol. 259, 81\u201392 (2023).","journal-title":"J. Pathol."},{"key":"2482_CR13","doi-asserted-by":"publisher","first-page":"103030","DOI":"10.1016\/j.ebiom.2020.103030","volume":"61","author":"Y Zhao","year":"2020","unstructured":"Zhao, Y. et al. CUP-AI-Dx: a tool for inferring cancer tissue of origin and molecular subtype using RNA gene-expression data and artificial intelligence. EBioMedicine 61, 103030 (2020).","journal-title":"EBioMedicine"},{"key":"2482_CR14","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","volume":"7","author":"APG Consortium","year":"2017","unstructured":"Consortium, A. P. G. et al. AACR project GENIE: powering precision medicine through an international consortium. Cancer Discov. 7, 818\u2013831 (2017).","journal-title":"Cancer Discov."},{"key":"2482_CR15","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1200\/JCO.2012.43.3755","volume":"31","author":"JD Hainsworth","year":"2013","unstructured":"Hainsworth, J. D. et al. Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon Research Institute. J. Clin. Oncol. 31, 217\u2013223 (2013).","journal-title":"J. Clin. Oncol."},{"key":"2482_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1093\/annonc\/mdv543","volume":"27","author":"H Yoon","year":"2016","unstructured":"Yoon, H. et al. Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance). Ann. Oncol. 27, 339\u2013344 (2016).","journal-title":"Ann. Oncol."},{"key":"2482_CR17","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1001\/jamaoncol.2020.4643","volume":"6","author":"H Hayashi","year":"2020","unstructured":"Hayashi, H. et al. Site-specific and targeted therapy based on molecular profiling by next-generation sequencing for cancer of unknown primary site: a nonrandomized phase 2 clinical trial. JAMA Oncol. 6, 1931\u20131938 (2020).","journal-title":"JAMA Oncol."},{"key":"2482_CR18","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1200\/JCO.18.00771","volume":"37","author":"H Hayashi","year":"2019","unstructured":"Hayashi, H. et al. Randomized phase II trial comparing site-specific treatment based on gene expression profiling with carboplatin and paclitaxel for patients with cancer of unknown primary site. J. Clin. Oncol. 37, 570\u2013579 (2019).","journal-title":"J. Clin. Oncol."},{"key":"2482_CR19","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1200\/JCO.19.00449","volume":"37","author":"A-M Conway","year":"2019","unstructured":"Conway, A.-M., Mitchell, C. & Cook, N. Challenge of the unknown: how can we improve clinical outcomes in cancer of unknown primary? J. Clin. Oncol. 37, 2089\u20132090 (2019).","journal-title":"J. Clin. Oncol."},{"key":"2482_CR20","doi-asserted-by":"crossref","unstructured":"Chen, T. & Guestrin, C. XGBoost: a scalable tree boosting system. In Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining (KDD \u201916). 785\u2013794 (Association for Computing Machinery, 2016).","DOI":"10.1145\/2939672.2939785"},{"key":"2482_CR21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fonc.2019.00402","volume":"9","author":"T Bochtler","year":"2019","unstructured":"Bochtler, T. & Kr\u00e4mer, A. Does cancer of unknown primary (CUP) truly exist as a distinct cancer entity? Front. Oncol. 9, 402 (2019).","journal-title":"Front. Oncol."},{"key":"2482_CR22","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg, S. M. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56\u201367 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"2482_CR23","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate, J. G. et al. Cosmic: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 47, D941\u2013D947 (2019).","journal-title":"Nucleic Acids Res."},{"key":"2482_CR24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-pathol-011110-130206","volume":"6","author":"G da Cunha Santos","year":"2011","unstructured":"da Cunha Santos, G., Shepherd, F. A. & Tsao, M. S. EGFR mutations and lung cancer. Annu. Rev. Pathol. 6, 49\u201369 (2011).","journal-title":"Annu. Rev. Pathol."},{"key":"2482_CR25","doi-asserted-by":"publisher","first-page":"78985","DOI":"10.18632\/oncotarget.12587","volume":"7","author":"Y-L Zhang","year":"2016","unstructured":"Zhang, Y.-L. et al. The prevalence of EGFR mutation in patients with non-small cell lung cancer: a systematic review and meta-analysis. Oncotarget 7, 78985 (2016).","journal-title":"Oncotarget"},{"key":"2482_CR26","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/jnci\/91.14.1194","volume":"91","author":"SS Hecht","year":"1999","unstructured":"Hecht, S. S. Tobacco smoke carcinogens and lung cancer. J. Natl Cancer Inst. 91, 1194\u20131210 (1999).","journal-title":"J. Natl Cancer Inst."},{"key":"2482_CR27","doi-asserted-by":"publisher","first-page":"7033","DOI":"10.1007\/s13277-016-4924-2","volume":"37","author":"E Dirican","year":"2016","unstructured":"Dirican, E., Akkiprik, M. & \u00d6zer, A. Mutation distributions and clinical correlations of PIK3CA gene mutations in breast cancer. Tumor Biol. 37, 7033\u20137045 (2016).","journal-title":"Tumor Biol."},{"key":"2482_CR28","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s10549-007-9659-8","volume":"109","author":"S Elsheikh","year":"2008","unstructured":"Elsheikh, S. et al. CCND1 amplification and cyclin D1 expression in breast cancer and their relation with proteomic subgroups and patient outcome. Breast Cancer Res. Treat. 109, 325\u2013335 (2008).","journal-title":"Breast Cancer Res. Treat."},{"key":"2482_CR29","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1136\/gut.2005.083063","volume":"55","author":"J Kim","year":"2006","unstructured":"Kim, J. et al. Unfavourable prognosis associated with K-ras gene mutation in pancreatic cancer surgical margins. Gut 55, 1598\u20131605 (2006).","journal-title":"Gut"},{"key":"2482_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1053\/j.seminoncol.2021.02.003","volume":"48","author":"J Luo","year":"2021","unstructured":"Luo, J. KRAS mutation in pancreatic cancer. Semin. Oncol. 48, 10\u201318 (2021).","journal-title":"Semin. Oncol."},{"key":"2482_CR31","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41416-018-0332-2","volume":"120","author":"AM Conway","year":"2019","unstructured":"Conway, A. M. et al. Molecular characterisation and liquid biomarkers in carcinoma of unknown primary (CUP): taking the \u2018U\u2019 out of \u2018CUP\u2019. Br. J. Cancer 120, 141\u2013153 (2019).","journal-title":"Br. J. Cancer"},{"key":"2482_CR32","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/s41591-022-01873-5","volume":"28","author":"R Liu","year":"2022","unstructured":"Liu, R. et al. Systematic pan-cancer analysis of mutation\u2013treatment interactions using large real-world clinicogenomics data. Nat. Med. 28, 1656\u20131661 (2022).","journal-title":"Nat. Med."},{"key":"2482_CR33","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41586-021-03430-5","volume":"592","author":"R Liu","year":"2021","unstructured":"Liu, R. et al. Evaluating eligibility criteria of oncology trials using real-world data and AI. Nature 592, 629\u2013633 (2021).","journal-title":"Nature"},{"key":"2482_CR34","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1093\/biomet\/81.3.515","volume":"81","author":"PM Grambsch","year":"1994","unstructured":"Grambsch, P. M. & Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81, 515\u2013526 (1994).","journal-title":"Biometrika"},{"key":"2482_CR35","first-page":"PO.17.00011","volume":"1","author":"D Chakravarty","year":"2017","unstructured":"Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. JCO Precis. Oncol. 1, PO.17.00011 (2017).","journal-title":"JCO Precis. Oncol."},{"key":"2482_CR36","doi-asserted-by":"publisher","first-page":"2566","DOI":"10.1158\/2159-8290.CD-21-1443","volume":"12","author":"E Moiso","year":"2022","unstructured":"Moiso, E. et al. Developmental deconvolution for classification of cancer origin. Cancer Discov. 12, 2566\u20132585 (2022).","journal-title":"Cancer Discov."},{"key":"2482_CR37","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41586-021-03512-4","volume":"594","author":"MY Lu","year":"2021","unstructured":"Lu, M. Y. et al. AI-based pathology predicts origins for cancers of unknown primary. Nature 594, 106\u2013110 (2021).","journal-title":"Nature"},{"key":"2482_CR38","doi-asserted-by":"publisher","first-page":"v133","DOI":"10.1093\/annonc\/mdv305","volume":"26","author":"K Fizazi","year":"2015","unstructured":"Fizazi, K. et al. Cancers of unknown primary site: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 26, v133\u2013v138 (2015).","journal-title":"Ann. Oncol."},{"key":"2482_CR39","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.3390\/cancers14122905","volume":"14","author":"L Mileshkin","year":"2022","unstructured":"Mileshkin, L. et al. Cancer-of-unknown-primary-origin: a SEER\u2013Medicare study of patterns of care and outcomes among elderly patients in clinical practice. Cancers 14, 2905 (2022).","journal-title":"Cancers"},{"key":"2482_CR40","unstructured":"Moon, I., Groha, S., & Gusev, A. SurvLatent ODE: a neural ODE based time-to-event model with competing risks for longitudinal data improves cancer-associated venous thromboembolism (VTE) prediction. In Proceedings of the 7th Machine Learning for Healthcare Conference. 800\u2013 827 (PMLR, 2022)."},{"key":"2482_CR41","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1200\/CCI.20.00020","volume":"4","author":"KL Kehl","year":"2020","unstructured":"Kehl, K. L. et al. Natural language processing to ascertain cancer outcomes from medical oncologist notes. JCO Clin. Cancer Inform. 4, 680\u2013690 (2020).","journal-title":"JCO Clin. Cancer Inform."},{"key":"2482_CR42","doi-asserted-by":"publisher","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","volume":"141","author":"EP Garcia","year":"2017","unstructured":"Garcia, E. P. et al. Validation of oncopanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer. Arch. Pathol. Lab. Med. 141, 751\u2013758 (2017).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"2482_CR43","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jmoldx.2014.12.006","volume":"17","author":"DT Cheng","year":"2015","unstructured":"Cheng, D. T. et al. Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J. Mol. Diagn. 17, 251\u2013264 (2015).","journal-title":"J. Mol. Diagn."},{"key":"2482_CR44","doi-asserted-by":"publisher","first-page":"104006","DOI":"10.1088\/1361-6579\/aadf0f","volume":"39","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. Classification of short single-lead electrocardiograms (ECGs) for atrial fibrillation detection using piecewise linear spline and XGBoost. Physiol. Meas. 39, 104006 (2018).","journal-title":"Physiol. Meas."},{"key":"2482_CR45","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jad.2018.12.095","volume":"246","author":"CM Hatton","year":"2019","unstructured":"Hatton, C. M. et al. Predicting persistent depressive symptoms in older adults: a machine learning approach to personalised mental healthcare. J. Affect. Disord. 246, 857\u2013860 (2019).","journal-title":"J. Affect. Disord."},{"key":"2482_CR46","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1109\/TCBB.2019.2911071","volume":"17","author":"A Ogunleye","year":"2019","unstructured":"Ogunleye, A. & Wang, Q.-G. XGBoost model for chronic kidney disease diagnosis. IEEE\/ACM Trans. Comput. Biol. Bioinform. 17, 2131\u20132140 (2019).","journal-title":"IEEE\/ACM Trans. Comput. Biol. Bioinform."},{"key":"2482_CR47","first-page":"281","volume":"13","author":"J Bergstra","year":"2012","unstructured":"Bergstra, J. & Bengio, Y. Random search for hyper-parameter optimization. J. Mach. Learn. Res. 13, 281\u2013305 (2012).","journal-title":"J. Mach. Learn. Res."},{"key":"2482_CR48","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94\u2013101 (2020).","journal-title":"Nature"},{"key":"2482_CR49","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal, R., McGranahan, N., Herrero, J., Taylor, B. S. & Swanton, C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 17, 31 (2016).","journal-title":"Genome Biol."},{"key":"2482_CR50","unstructured":"Janzing, D., Minorics, L. & Bl\u00f6baum, P. Feature relevance quantification in explainable AI: a causal problem. In Proceedings of International Conference on Artificial Intelligence and Statistics 2907\u20132916 (PMLR, 2020)."},{"key":"2482_CR51","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13073-021-00999-4","volume":"13","author":"A Gusev","year":"2021","unstructured":"Gusev, A., Groha, S., Taraszka, K., Semenov, Y. R. & Zaitlen, N. Constructing germline research cohorts from the discarded reads of clinical tumor sequences. Genome Med. 13, 179 (2021).","journal-title":"Genome Med."},{"key":"2482_CR52","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. Ser. B Methodol. 34, 187\u2013202 (1972).","journal-title":"J. R. Stat. Soc. Ser. B Methodol."},{"key":"2482_CR53","doi-asserted-by":"publisher","first-page":"3089","DOI":"10.1002\/sim.2174","volume":"24","author":"J Xie","year":"2005","unstructured":"Xie, J. & Liu, C. Adjusted Kaplan\u2013Meier estimator and log-rank test with inverse probability of treatment weighting for survival data. Stat. Med. 24, 3089\u20133110 (2005).","journal-title":"Stat. Med."},{"key":"2482_CR54","doi-asserted-by":"publisher","first-page":"12","DOI":"10.32614\/RJ-2011-012","volume":"3","author":"I Marschner","year":"2011","unstructured":"Marschner, I. glm2: Fitting generalized linear models with convergence problems. The R Journal 3, 12\u201315 (2011).","journal-title":"The R Journal"}],"updated-by":[{"DOI":"10.1038\/s41591-023-02693-x","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000}}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02482-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02482-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02482-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T16:48:14Z","timestamp":1729874894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41591-023-02482-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["2482"],"URL":"https:\/\/doi.org\/10.1038\/s41591-023-02482-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2450090\/v1","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"6 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41591-023-02693-x","URL":"https:\/\/doi.org\/10.1038\/s41591-023-02693-x","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}